ALEXANDRIA, Va., June 10 -- United States Patent no. 12,291,539, issued on May 6, was assigned to Frontier Medicines Corp. (South San Francisco, Calif.).
"KRAS G12C inhibitors" was invented by Snahel Patel (Foster City, Calif.), Philip A. Gerken (San Francisco) and Monika Jane Williams (Woodside, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds and methods useful in the treatment and suppression of cancer, for example, useful for treating or suppressing cancers characterized by KRAS G12C. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds."
The patent was filed on July 24, 2024, under Application N...